keyword
https://read.qxmd.com/read/38633835/clinical-variables-associated-with-major-adverse-cardiac-events-following-radical-cystectomy
#1
JOURNAL ARTICLE
Aaron A Gurayah, Ruben Blachman-Braun, Christopher J Machado, Matthew M Mason, Helen Y Hougen, Ali Mouzannar, Mark L Gonzalgo, Bruno Nahar, Sanoj Punnen, Dipen J Parekh, Chad R Ritch
OBJECTIVES: The objective of this study is to investigate the association between major adverse cardiac events (MACE) and clinical factors of patients undergoing radical cystectomy (RC) for bladder cancer. MATERIALS AND METHODS: A retrospective analysis using the 2015-2020 National Surgical Quality Improvement Program database was performed on patients who underwent RC for bladder cancer. MACE was defined as any report of cerebrovascular accident, myocardial infarction, or thromboembolic events (pulmonary embolism or deep vein thrombosis)...
April 2024: BJUI compass
https://read.qxmd.com/read/38633827/the-potential-role-of-precision-medicine-to-alleviate-racial-disparities-in-prostate-bladder-and-renal-urological-cancer-care
#2
REVIEW
Kunal K Sindhu, Zachary Dovey, Marcher Thompson, Anthony D Nehlsen, Karin A Skalina, Beata Malachowska, Shaakir Hasan, Chandan Guha, Justin Tang, Lucas Resende Salgado
BACKGROUND: Racial disparities in oncological outcomes resulting from differences in social determinants of health (SDOH) and tumour biology are well described in prostate cancer (PCa) but similar inequities exist in bladder (BCa) and renal cancers (RCCs). Precision medicine (PM) aims to provide personalized treatment based on individual patient characteristics and has the potential to reduce these inequities in GU cancers. OBJECTIVE: This article aims to review the current evidence outlining racial disparities in GU cancers and explore studies demonstrating improved oncological outcomes when PM is applied to racially diverse patient populations...
April 2024: BJUI compass
https://read.qxmd.com/read/38633286/discordant-molecular-imaging-findings-with-2-18-f-fdg-and-68-ga-ga-psma-pet-ct-in-a-patient-with-both-bladder-and-prostate-cancer
#3
JOURNAL ARTICLE
Aparna Mahalik, Jasim Jaleel, Sambit Sagar, Dikhra Khan, Shobhana Raju, Rakesh Kumar
The prevalence of double primary prostate and bladder cancer is not uncommon. Though both share a common pathway of malignant transformation, they bear to differ in the case of 2-[18 F]FDG PET/CT and [68 Ga]Ga-PSMA uptake. We present a case of double primary cancer involving the bladder and prostate, where the prostatic primary showed intense [68 Ga]Ga-PSMA uptake with non-avid skeletal and pulmonary metastases, which showed intense 2-[18 F]FDG uptake, thus showing discordance due to different clonal origins...
May 2024: Nuclear Medicine and Molecular Imaging
https://read.qxmd.com/read/38631192/gastric-outlet-obstruction-as-a-presentation-of-metastatic-squamous-cell-carcinoma-of-the-bladder-a-case-report-and-review-of-the-literature
#4
Jana H Mahdi, Baraa AlJardali, Oussama G Nasrallah, Noura El Sayegh, Marwan Zein, Rami W Nasr
INTRODUCTION: Gastric outlet obstruction presents with a range of symptoms which include abdominal pain, early satiety, weight loss and vomiting caused obstruction secondary to tumors from outside the gastrointestinal tract or due to motility disorders. Bladder cancer is rarely associated with Gastric outlet obstruction. It usually presents with painless hematuria and urinary symptoms. Squamous cell carcinoma is a subtype of bladder malignancies that tends to present at a later stage and is associated with poorer prognosis in terms of metastasis and survival...
April 9, 2024: International Journal of Surgery Case Reports
https://read.qxmd.com/read/38631104/real-world-analysis-of-peritoneal-metastasis-from-renal-cell-carcinoma-meet-uro27
#5
JOURNAL ARTICLE
Marco Stellato, Sebastiano Buti, Marco Maruzzo, Maria Bassanelli, Melissa Bersanelli, Marilena Di Napoli, Michele Dionese, Martina Fanelli, Roberto Filippi, Giuseppe Fotia, Luca Galli, Francesco Grillone, Michele Maffezzoli, Brigida Anna Maiorano, Cecilia Nasso, Sara Elena Rebuzzi, Luca Lalli, Giandomenico Roviello, Mariella Sorarù, Bruno Vincenzi, Giuseppe Procopio, Elena Verzoni
BACKGROUND: Peritoneal metastases (PM) have been reported in approximately 1% of patients with metastatic Renal Cell Carcinoma (mRCC). Outcome data are limited due to the rarity of this metastatic site. Therefore, the aim of our study is to describe renal cell carcinoma (RCC) patients with PM treated as per clinical practice. MATERIALS AND METHODS: Baseline characteristics and outcome data of patients with PM from RCC were retrospectively collected from 18 Italian oncological referral centers adhering to the Meet-Uro group, from January 2016 to January 2023...
March 19, 2024: Clinical Genitourinary Cancer
https://read.qxmd.com/read/38627150/european-association-of-urology-european-society-for-paediatric-urology-guidelines-on-paediatric-urology-summary-of-the-2024-updates
#6
REVIEW
Michele Gnech, Allon van Uitert, Uchenna Kennedy, Martin Skott, Alexandra Zachou, Berk Burgu, Marco Castagnetti, Lisette't Hoen, Fardod O'Kelly, Josine Quaedackers, Yazan F Rawashdeh, Mesrur Selcuk Silay, Guy Bogaert, Christian Radmayr
BACKGROUND AND OBJECTIVE: We present an overview of the 2024 updates for the European Association of Urology (EAU)/European Society for Paediatric Urology (ESPU) guidelines on paediatric urology to offer evidence-based standards for perioperative management, minimally invasive surgery (MIS), hydrocele, congenital lower urinary tract obstruction (CLUTO), trauma/emergencies, and fertility preservation. METHODS: A broad literature search was performed for each condition...
April 15, 2024: European Urology
https://read.qxmd.com/read/38626661/a-randomized-double-blind-placebo-controlled-trial-evaluating-the-effect-of-topical-urea-for-secondary-prophylaxis-of-hand-foot-skin-reaction-in-renal-cell-cancer-patients-on-sunitinib-therapy
#7
JOURNAL ARTICLE
Syed Shariq Naeem, Pooja Gupta, Ranjit Kumar Sahoo, V L Kumar, T Velpandian, Archana Singh, Atul Batra, Raja Pramanik, Sameer Rastogi, Saumya Srivastava
INTRODUCTION: Hand foot skin reaction (HFSR) is a common dose-limiting adverse effect of multi kinase inhibitors (MKI) whose mechanism is not fully understood, and the prophylaxis is inadequate. OBJECTIVE: In this pilot study, a double-blind, randomized placebo-controlled trial was conducted to evaluate the effect of topical urea in secondary prevention of sunitinib-induced HFSR in renal cell cancer patients. METHODS: Out of 55 screened patients, 14 were randomized to receive topical urea or placebo for four weeks...
March 13, 2024: Clinical Genitourinary Cancer
https://read.qxmd.com/read/38626660/adrenocortical-cancer-in-the-real-world-a-comprehensive-analysis-of-clinical-features-and-management-from-the-turkish-oncology-group-tog
#8
JOURNAL ARTICLE
Hatime Arzu Yasar, Burak Yasin Aktas, Gokhan Ucar, Sema Sezgin Goksu, Irem Bilgetekin, Burcu Cakar, Abdullah Sakin, Ozturk Ates, Tugba Basoglu, Cagatay Arslan, Atike Gokcen Demiray, Semra Paydas, Irfan Cicin, Mehmet Ali Nahit Sendur, Nuri Karadurmus, Hakan Kosku, Aytuğ Uner, Perran Fulden Yumuk, Gungor Utkan, Umut Kefeli, Ozgur Tanriverdi, Havva Cinkir, Ozge Gumusay, Nazım Serdal Turhal, Serkan Menekse, Engin Kut, Ismail Beypinar, Teoman Sakalar, Hacer Demir, Emre Yekeduz, Saadettin Kilickap, Mustafa Erman, Yuksel Urun
INTRODUCTION: Adrenocortical carcinoma (ACC) is a rare yet highly malignant tumor associated with significant morbidity and mortality. This study aims to delineate the clinical features, survival patterns, and treatment modalities of ACC, providing insights into the disease's prognosis. MATERIALS AND METHODS: A retrospective analysis of 157 ACC patients was performed to assess treatment methodologies, demographic patterns, pathological and clinical attributes, and laboratory results...
March 15, 2024: Clinical Genitourinary Cancer
https://read.qxmd.com/read/38622957/trimodal-therapy-vs-radical-cystectomy-in-patients-with-muscle-invasive-bladder-cancer-a-systematic-review-and-meta-analysis-of-comparative-studies
#9
REVIEW
Francesco Ditonno, Alessandro Veccia, Francesca Montanaro, Greta Pettenuzzo, Antonio Franco, Celeste Manfredi, Luca Triggiani, Cosimo De Nunzio, Marco De Sio, Mariangela Cerruto, Simone Crivellaro, Alexander Kutikov, Riccardo Autorino, Alessandro Antonelli
OBJECTIVE: To perform a systematic review and meta-analysis of trials comparing trimodal therapy (TMT) and radical cystectomy (RC), evaluating differences in terms of oncological outcomes, quality of life, and costs. MATERIALS AND METHODS: In July 2023, a literature search of multiple databases was conducted to identify studies analysing patients with cT2-4 N any M0 muscle-invasive bladder cancer (MIBC; Patients) receiving TMT (Intervention) compared to RC (Comparison), to evaluate survival outcomes, recurrence rates, costs, and quality of life (Outcomes)...
April 15, 2024: BJU International
https://read.qxmd.com/read/38616147/clinical-outcomes-and-prognostic-factors-in-patients-with-penile-carcinoma-a-sub-analysis-from-meet-uro-23-i-rare-registry-study
#10
JOURNAL ARTICLE
Veronica Mollica, Francesco Massari, Marco Maruzzo, Davide Bimbatti, Melanie Claps, Brigida Anna Maiorano, Maria Giuseppa Vitale, Roberto Iacovelli, Paola Ermacora, Giandomenico Roviello, Fabio Calabrò, Orazio Caffo, Francesca Vignani, Francesco Grillone, Francesco Pierantoni, Marilena Di Napoli, Alessia Mennitto, Andrea Marchetti, Alvise Mattana, Alessia Cavo, Maria Bassanelli, Luigi Formisano, Veronica Prati, Giulia Claire Giudice, Sebastiano Buti
INTRODUCTION: Penile squamous cell carcinoma (PSCC) is a rare tumor with an aggressive behavior. The Meet-URO 23/I-RARE registry includes rare genitourinary malignancies. We extracted patients with PSCC to conduct a retrospective study aimed at assessing clinical outcomes and prognostic factors. PATIENTS AND METHODS: Primary endpoints were overall survival and progression-free survival. Prognostic factors for OS and PFS were analyzed using univariate and multivariate analysis...
March 18, 2024: Clinical Genitourinary Cancer
https://read.qxmd.com/read/38615487/nlr-outperforms-low-hemoglobin-and-high-platelet-count-as-predictive-and-prognostic-biomarker-in-metastatic-renal-cell-carcinoma-treated-with-immune-checkpoint-inhibitors
#11
JOURNAL ARTICLE
Matthew Young, Jose C Tapia, Bernadett Szabados, Agne Jovaisaite, Francesca Jackson-Spence, Elizabeth Nally, Thomas Powles
BACKGROUND: Reliable biomarkers in renal cell carcinoma (RCC) remain elusive. While several markers have been shown to be associated with prognosis, and may aid in risk assessment, predictive biomarkers of response to immune checkpoint inhibitors (ICIs) have not been established. Previous studies have shown that a high pretreatment neutrophil-lymphocyte ratio (NLR) is a negative prognostic factor in RCC. However, a clinically useful cut-off for the predictive and prognostic value of NLR has not been well defined...
March 8, 2024: Clinical Genitourinary Cancer
https://read.qxmd.com/read/38615286/incidence-and-molecular-characteristics-of-deficient-mismatch-repair-conditions-across-nine-different-tumors-and-identification-of-germline-variants-involved-in-lynch-like-syndrome
#12
JOURNAL ARTICLE
Tetsuya Ito, Tatsuro Yamaguchi, Kensuke Kumamoto, Okihide Suzuki, Noriyasu Chika, Satoru Kawakami, Tomonori Nagai, Tsukasa Igawa, Kenji Fujiyoshi, Yoshito Akagi, Tomio Arai, Kiwamu Akagi, Hidetaka Eguchi, Yasushi Okazaki, Hideyuki Ishida
BACKGROUND: Based on molecular characteristics, deficient DNA mismatch repair (dMMR) solid tumors are largely divided into three categories: somatically MLH1-hypermethylated tumors, Lynch syndrome (LS)-associated tumors, and Lynch-like syndrome (LLS)-associated tumors. The incidence of each of these conditions and the corresponding pathogenic genes related to LLS remain elusive. METHODS: We identified dMMR tumors in 3609 tumors from 9 different solid organs, including colorectal cancer, gastric cancer, small-bowel cancer, endometrial cancer, ovarian cancer, upper urinary tract cancer, urinary bladder cancer, prostate cancer, and sebaceous tumor, and comprehensively summarized the characterization of dMMR tumors...
April 14, 2024: International Journal of Clinical Oncology
https://read.qxmd.com/read/38615202/plasma-metadherin-mrna-expression-in-bladder-cancer
#13
JOURNAL ARTICLE
Zeinab A Abd Elhameed, Lubna M Tag El Din, Tahra Sherif, Amal M Abdel Aal, Ahmed M Moeen, Esraa N Abd El Hakeem, Eman M Abdelrahman
Urinary bladder cancer (BC) is the ninth most common cancer worldwide. At present, the clinical diagnosis of BC depends on self-reported symptoms, tissue biopsy specimens by cystoscopy and from voided urine cytology. However, cystoscopy is an invasive examination and voided urine cytology has low sensitivity, which might provoke misdiagnosis. The search for cancer biomarkers in blood is worthy of intense attention due to patients' comfort and ease of sampling. This work aimed to study expression of mRNA metadherin (MTDH) in plasma, serum BC specific antigen 1 (BLCA-1) and cystatin C as biomarkers of BC and their relation to different disease stages...
April 2024: Egyptian Journal of Immunology
https://read.qxmd.com/read/38614853/impact-of-preoperative-plasma-potassium-levels-on-oncological-outcomes-major-complications-and-30-day-mortality-in-bladder-cancer-patients-undergoing-radical-cystectomy
#14
JOURNAL ARTICLE
Jakob Klemm, Shahrokh F Shariat, Ekaterina Laukhtina, Pawel Rajwa, Malte W Vetterlein, Victor M Schuettfort, Markus von Deimling, Roland Dahlem, Margit Fisch, Michael Rink
INTRODUCTION AND OBJECTIVES: We examined the impact of preoperative plasma potassium levels (PPLs) on outcomes in patients undergoing radical cystectomy (RC) for urothelial carcinoma of the bladder (UCB), hypothesizing that potassium imbalances might influence outcomes. PATIENTS AND METHODS: In this retrospective study, 501 UCB patients undergoing RC from 2009 to 2017 at a tertiary center were analyzed. Blood samples collected a week prior to surgery defined normal and abnormal PPL based on institutional standards...
March 21, 2024: Clinical Genitourinary Cancer
https://read.qxmd.com/read/38610970/non-surgical-bladder-sparing-multimodal-management-in-organ-confined-urothelial-carcinoma-of-the-urinary-bladder-a-population-based-analysis
#15
JOURNAL ARTICLE
Mario de Angelis, Andrea Baudo, Carolin Siech, Letizia Maria Ippolita Jannello, Francesco Di Bello, Jordan A Goyal, Zhe Tian, Nicola Longo, Ottavio de Cobelli, Felix K H Chun, Fred Saad, Shahrokh F Shariat, Luca Carmignani, Giorgio Gandaglia, Marco Moschini, Francesco Montorsi, Alberto Briganti, Pierre I Karakiewicz
BACKGROUND: Trimodal therapy is considered the most validated bladder-sparing treatment in patients with organ-confined urothelial carcinoma of the urinary bladder (T2N0M0). However, scarce evidence exists regarding cancer-specific mortality (CSM) differences between trimodal therapy and other non-extirpative multimodal treatment options such as radiotherapy alone after transurethral resection (TURBT + RT) or chemotherapy alone after transurethral resection (TURBT + CT). METHODS: Within the Surveillance, Epidemiology, and End Results database (2004-2020), we identified T2N0M0 patients treated with either trimodal therapy, TURBT + CT, or TURBT + RT...
March 27, 2024: Cancers
https://read.qxmd.com/read/38610933/urodynamic-parameters-and-continence-outcomes-in-asymptomatic-patients-with-ileal-orthotopic-neobladder-a-systematic-review-and-metanalysis
#16
REVIEW
Anastasios D Asimakopoulos, Enrico Finazzi Agrò, Thierry Piechaud, Georgios Gakis, Richard Gaston, Eleonora Rosato
INTRODUCTION: The orthotopic neobladder is the type of urinary diversion (UD) that most closely resembles the original bladder. However, in the literature the urodynamic aspects are scarcely analysed. OBJECTIVE: To provide the first systematic review (SR) on the urodynamic (UDS) outcomes of the ileal orthotopic neobladders (ONB). Continence outcomes are also presented. METHODS: A PubMed, Embase and Cochrane CENTRAL search for peer-reviewed studies on ONB published between January 2001-December 2022 was performed according to the Preferred Reporting Items for Systematic Review and Meta-analysis (PRISMA) statement...
March 22, 2024: Cancers
https://read.qxmd.com/read/38610796/treating-bcg-induced-cystitis-with-combined-chondroitin-and-hyaluronic-acid-instillations-in-bladder-cancer
#17
JOURNAL ARTICLE
Renate Pichler, Johannes Stäblein, Andrea Mari, Luca Afferi, David D'Andrea, Gautier Marcq, Francesco Del Giudice, Francesco Soria, Jorge Caño-Velasco, José Daniel Subiela, Andrea Gallioli, Karl H Tully, Keiichiro Mori, Achim Herms, Benjamin Pradere, Marco Moschini, Laura S Mertens, Martin Thurnher
In non-muscle invasive bladder cancer, Bacillus Calmette-Guérin (BCG) responders benefit from strong Th1-type inflammatory and T cell responses mediating tumor rejection. However, the corresponding lack of anti-inflammatory Th2-type immunity impairs tissue repair in the bladder wall and facilitates the development of cystitis, causing urinary pain, urgency, incontinence, and frequency. Mechanistically, the leakage of the glycosaminoglycan (GAG) layer enables an influx of potassium ions, bacteria, and urine solutes towards the underlying bladder tissue, promoting chronic inflammation...
March 31, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38608334/detection-of-the-highest-grade-lesion-in-multifocal-discordant-prostate-cancer-by-multiparametric-magnetic-resonance-imaging
#18
JOURNAL ARTICLE
Kazuhiro Matsumoto, Hirotaka Akita, Akinori Hashiguchi, Toshikazu Takeda, Takeo Kosaka, Keishiro Fukumoto, Yota Yasumizu, Nobuyuki Tanaka, Shinya Morita, Ryuichi Mizuno, Hiroshi Asanuma, Mototsugu Oya, Masahiro Jinzaki
PURPOSE: Prostate cancer generally occurs multifocally. The lesions of the largest size and highest-grade are often concordant, and defined as an index tumor. However, these factors sometimes do not coincide within one lesion. In such discordant cases, not the largest size lesion but the highest-grade lesion is known to determine the prognosis. We focused on the multiparametric magnetic resonance imaging (mpMRI) detectability of the highest-grade tumors in discordant cases. MATERIALS AND METHODS: We investigated the detectability of the highest-grade tumor using preoperative mpMRI in 50 discordant patients who underwent radical prostatectomy...
March 21, 2024: Clinical Genitourinary Cancer
https://read.qxmd.com/read/38606522/modified-three-layer-vesicourethral-reconstruction-in-robot-assisted-radical-prostatectomy-can-change-cystography-pattern-and-improve-early-recovery-of-continence
#19
JOURNAL ARTICLE
Hung-Yi Chen, Jui-Ming Liu, I-Hung Shao, Kuan-Lin Liu, Cheng-Feng Lin, Ching-Wen Chang, Cheng-Chia Lin, Chun-Te Wu
BACKGROUND AND OBJECTIVES: To determine early continence outcomes after three-layer vesicourethral reconstruction during robot-assisted radical prostatectomy (RARP) and the role of postoperative cystography pattern. METHODS: Between May 2015 and January 2019, a total of 170 consecutive patients with localized prostate cancer who underwent RARP, were divided into one- and three-layer groups based on the method of vesicourethral reconstruction. Continent status, preoperative, intraoperative, postoperative, clinicopathological variables, and cystography parameters were analyzed...
April 12, 2024: Journal of Surgical Oncology
https://read.qxmd.com/read/38602577/aso-author-reflections-changes-in-the-urinary-microbiome-after-transurethral-resection-of-nonmuscle-invasive-bladder-cancer-insights-from-a-prospective-observational-study
#20
JOURNAL ARTICLE
Aleksander Ślusarczyk
No abstract text is available yet for this article.
April 11, 2024: Annals of Surgical Oncology
keyword
keyword
169814
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.